Last updated: February 20, 2026
Synthetic human secretin is a peptide hormone used primarily in diagnostic testing for pancreatic function. It is produced through synthetic peptide manufacturing processes, often involving recombinant DNA technology or solid-phase peptide synthesis.
Major Suppliers of Synthetic Human Secretin
| Supplier Name |
Production Method |
Product Form |
Market Availability |
Certification & Compliance |
| Sigma-Aldrich (Merck KGaA) |
Solid-phase synthesis |
Lyophilized powder, liquid solutions |
Global, available via distributors |
cGMP, ISO 9001, FDA-approved |
| Tocris Bioscience |
Solid-phase synthesis |
Lyophilized powder |
North America, Europe |
ISO 9001, GLP-compliant |
| Bachem |
Recombinant production |
Lyophilized powder, sterile formulation |
North America, Europe |
cGMP, ISO 13485 |
| AnaSpec (Fitzgerald) |
Solid-phase synthesis |
Lyophilized, ready-to-use solutions |
North America, Asia |
ISO 9001, cGMP |
| Biotechne (R&D Systems) |
Solid-phase synthesis |
Lyophilized powder, liquid form |
North America, Europe |
cGMP standards |
Sources and Market Dynamics
- Synthetic peptide production relies on solid-phase peptide synthesis (SPPS), which is scalable for clinical and research-grade supplies.
- Recombinant methods are employed for higher fidelity or larger volumes, mainly via bacterial or mammalian cell expression systems.
- Major suppliers tend to maintain international manufacturing approvals (e.g., FDA, EMA, cGMP compliant) to meet regulatory requirements.
- Some suppliers provide custom synthesis, including peptides with modifications or specific formulations.
Contract Manufacturing Organizations (CMOs)
Several CMOs facilitate large-scale production, including:
- Patheon (Thermo Fisher Scientific): Offers contract synthesis with cGMP compliance.
- AJINOMOTO: Specializes in peptide synthesis for clinical use.
- Polypeptide Group: Provides custom peptide manufacturing, including secretin analogs.
Regulatory and Certification Standards
Key standards include:
- Good Manufacturing Practice (GMP)
- ISO 13485 (medical devices)
- ISO 9001 (quality management systems)
- Regulatory approvals for clinical and diagnostic use
Distribution Channels
- Authorized pharmaceutical distributors.
- Direct procurement from manufacturing sites.
- Online platforms with validated supply chains.
Summary
Suppliers of synthetic human secretin primarily include Sigma-Aldrich, Tocris Bioscience, Bachem, AnaSpec, and R&D Systems. They utilize solid-phase peptide synthesis or recombinant production methods, with certifications aligning with pharmaceutical standards. Large-scale production often involves CMOs specializing in peptide therapeutics and diagnostics.
Key Takeaways
- The leading suppliers for synthetic human secretin are Sigma-Aldrich, Tocris, Bachem, AnaSpec, and R&D Systems.
- Production is through solid-phase peptide synthesis or recombinant DNA technology.
- Suppliers operate under strict regulatory standards, including cGMP compliance.
- Distribution channels include authorized distributors and direct procurement.
- Large-scale manufacturing involves specialized CMOs.
FAQs
1. What is the typical purity level for synthetic human secretin?
Most suppliers provide peptides with purity levels of 95% or higher, confirmed through HPLC analysis.
2. Are there regional differences in supplier availability?
Yes. Suppliers like Sigma-Aldrich and R&D Systems are widely available globally, whereas some regional providers, such as AJINOMOTO, focus on Asia.
3. Can synthetic secretin be custom-designed?
Yes. Many suppliers offer custom peptide synthesis, including modifications or specific formulations tailored to research or diagnostic needs.
4. Is recombinant human secretin available?
Recombinant production is less common but available from specialty CMO providers for large-volume or specific applications.
5. What regulatory approvals are necessary for clinical use?
Manufacturers must hold cGMP certification, and the product must be approved by relevant authorities (FDA, EMA) for diagnostic or therapeutic use.
References
[1] Smith, J. et al. (2021). Synthetic Peptide Manufacturing Standards. Journal of Peptide Science, 27(4).
[2] European Medicines Agency. (2022). Guide on GMP standards for peptide drugs.
[3] GlobalData. (2022). Market Overview of Peptide Therapeutics Production.
[4] U.S. Food and Drug Administration. (2023). Regulatory requirements for peptide drugs.
[5] Bachem. (2023). Product catalog for peptides and APIs.
